You must log in to view this webinar.

Coronary Calcium Scanning: Role in Preventive Cardiology


Nathan D. Wong, PhD, MPH, FACC, FAHA

Professor and Director

Heart Disease Prevention Program

Division of Cardiology, University of CA, Irvine

Past President, American Society for Preventive Cardiology (ASPC)

Time of Talk

45 minutes


This webinar will review the studies supporting the use of coronary calcium scoring and its recommendation in the new 2018 cholesterol management guidelines.

Learning Objectives

  1. Understand the background, pathophysiology of coronary calcium and rationale for coronary calcium screening
  2. Understand the relation of coronary calcium to future cardiovascular disease events and mortality
  3. Understand the benefits of coronary calcium screening
  4. Understand the current guidelines for coronary calcium screening and its role in choosing which patients are most suitable for treatment according to the 2018 cholesterol management guidelines


Research support– University of California, Irvine, Amgen, Amarin, Boehringer Ingelheim, and Novo Nordisk
Advisory board– Novartis, Amarin
Speaker– Amarin and Sanofi
Consulting– Astra-Zeneca

This enduring material activity, Coronary Calcium Scanning: Role in Preventive Cardiology, has been reviewed and is acceptable for up to 1.0 prescribed credits by the American Academy of Family Physicians. Term of approval begins June 28, 2019. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.